...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>International Journal of Technology Management: The Journal of the Technology Management of Technology, Engineering Management, Technology Policy and Strategy >Managing strategic innovation: an analysis of Dr. Reddy's Laboratories
【24h】

Managing strategic innovation: an analysis of Dr. Reddy's Laboratories

机译：管理战略创新：雷迪博士实验室的分析

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Dr. Reddy's laboratories (DRL) is a firm that is exploiting opportunities in the global market by planning and preparing for its growth through innovation and globalisation. DRL started its operation by leveraging strong process engineering skills. With India signing the WTO agreement and strengthening the IPR, DRL has firmed up its molecular discovery plans. The small size of the domestic market has made the company turn to the international markets through exports, acquisitions, mergers and joint ventures. The focus of DRL has been on achieving leadership in the Indian market through innovation and at the same time capitalising on the opportunities prevalent in the global market place. DRL has moved up the value chain by placing greater emphasis on its finished dosage market to gradually emerge as an important player in this segment. The major driver of growth has been the long term vision to dominate the market through innovation. [References: 5]
机译：Reddy博士实验室（DRL）是一家通过计划和准备通过创新和全球化来发展全球市场的公司。 DRL通过利用强大的过程工程技能来开始运营。随着印度签署了WTO协议并加强了知识产权保护，DRL巩固了其分子发现计划。国内市场的小规模使该公司通过出口，收购，合并和合资企业转向了国际市场。 DRL的重点一直是通过创新来实现在印度市场的领导地位，同时利用全球市场上普遍存在的机会。 DRL更加重视其成品药市场，从而逐步在价值链中占据了上风，从而逐渐成为该领域的重要参与者。增长的主要驱动力是通过创新来占领市场的长期愿景。 [参考：5]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号